Parallel Advisors’s Akcea Therapeutics Inc AKCA Stock Holding History

Parallel Advisors’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-445	Closed	-$8K	–	2824
2020 Q3	$8K	Sell	445 -455	-51%	-$6.46K	﹤0.01%	1869
2020 Q2	$12K	Hold	900	–	–	﹤0.01%	1662
2020 Q1	$12K	Buy	+900	New	+$14.8K	﹤0.01%	1545

Parallel Advisors's AKCA Position: Q4 2020 in Review

Parallel Advisors sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 445 shares — an estimated $8K sold.

Parallel Advisors first reported a position in AKCA in Q1 2020 and held it in 3 quarters. The position peaked at $12K in Q2 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Parallel Advisors reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Parallel Advisors sold 445 Akcea Therapeutics Inc shares in Q4 2020, an estimated $8K.
Parallel Advisors first reported a position in Akcea Therapeutics Inc in Q1 2020 and held it in 3 quarters.
Parallel Advisors's Akcea Therapeutics Inc position peaked at $12K in Q2 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Parallel Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.